Citadel Advisors’s T. Rowe Price Blue Chip Growth ETF TCHP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,428
Closed -$221K 14206
2025
Q4
$221K Buy
+4,428
New +$219K ﹤0.01% 10823
2025
Q1
Sell
-24,291
Closed -$1.02M 15543
2024
Q4
$1.02M Buy
+24,291
New +$1.01M ﹤0.01% 6963
2023
Q1
Sell
-34,447
Closed -$710K 15506
2022
Q4
$710K Buy
34,447
+12,980
+60% +$276K ﹤0.01% 7513
2022
Q3
$451K Buy
+21,467
New +$509K ﹤0.01% 8697
2022
Q1
Sell
-12,638
Closed -$419K 14555
2021
Q4
$419K Buy
+12,638
New +$421K ﹤0.01% 10105

Other funds holding TCHP

Citadel Advisors's TCHP Position: Q1 2026 in Review

Citadel Advisors sold out of T. Rowe Price Blue Chip Growth ETF (TCHP) in Q1 2026, closing a stake of 4,428 shares — an estimated $221K sold.

Citadel Advisors first reported a position in TCHP in Q4 2021 and held it in 5 quarters. The position peaked at $1.02M in Q4 2024. 176 funds tracked by Wall St. Rank hold TCHP as of Q1 2026.

  • Citadel Advisors reported no remaining T. Rowe Price Blue Chip Growth ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 4,428 T. Rowe Price Blue Chip Growth ETF shares in Q1 2026, an estimated $221K.
  • Citadel Advisors first reported a position in T. Rowe Price Blue Chip Growth ETF in Q4 2021 and held it in 5 quarters.
  • Citadel Advisors's T. Rowe Price Blue Chip Growth ETF position peaked at $1.02M in Q4 2024.
  • 176 funds tracked by Wall St. Rank held T. Rowe Price Blue Chip Growth ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.